Lyramid

Developer of midkine-based therapies intended to allow people to live longer, in good health. The company engages in the research and development of drugs with a focus on blocking midkine, a protein that plays an importa

placeAustralia language lyramid.com.au

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 6 times.

YearFilings
20221
20231
20241
20252
20261
Coming soon